Analyzing the impact of unexpected findings in radiology reports
Large scale clinical and economic impact analysis of potentially malignant incidental findings in radiology reports
['FUNDING_R01'] · UNIVERSITY OF WASHINGTON · NIH-10798146
This study is looking at unexpected cancer-related findings that show up in medical imaging reports to help improve follow-up care for patients and reduce unnecessary tests or treatments.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF WASHINGTON (nih funded) |
| Locations | 1 site (SEATTLE, UNITED STATES) |
| Trial ID | NIH-10798146 on ClinicalTrials.gov |
What this research studies
This research investigates the growing issue of incidental findings, or incidentalomas, that arise from imaging technologies. It aims to utilize natural language processing to identify cancer-related incidentalomas in radiology reports and to create a comprehensive database of these findings from over half a million patients. By analyzing this data, the research seeks to optimize follow-up care and improve health outcomes for patients who may be affected by these unexpected findings. The study will also address the potential for overinvestigation and unnecessary treatments that can arise from incidentalomas.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients who have undergone radiologic imaging and have received incidental findings in their reports.
Not a fit: Patients who have not had any imaging studies or those without incidental findings may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better management and follow-up of incidental findings, reducing unnecessary anxiety and healthcare costs for patients.
How similar studies have performed: Previous studies have highlighted the prevalence of incidental findings, but this research aims to take a novel, large-scale approach that has not been extensively tested.
Where this research is happening
SEATTLE, UNITED STATES
- UNIVERSITY OF WASHINGTON — SEATTLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: YETISGEN, MELIHA — UNIVERSITY OF WASHINGTON
- Study coordinator: YETISGEN, MELIHA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancers, neoplasm/cancer